Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q4 FY2021 Earnings Presentation
39 slides from Aster Dm Healthcare's earnings presentation, Jun 22, 2021
Slide 1: Aster – We'll Treat You Well
Aster We'll Treat You Well June 22, 2021 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Band
Slide 2: Investor Presentation – For Q4 & Year ended 31st March 2021
Investor Presentation – For Q4 & Year ended 31st March 2021 1
Slide 3: Disclaimer
I I Disclaimer This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other co
Slide 4: Aster – An Integrated Healthcare Provider; Operational and Financial Overview
I I ) - Aster – Overview ~ Aster – An Integrated Healthcare Provider ) ~ Operational and Financial Overview ) (j Strategy and Leadership ) 3
Slide 5: Aster DM Healthcare – Business Overview
I I Aster DM Healthcare – Business Overview HOSPITALS One of Largest Private CAPACITY BEDS healthcare service providers GCC: 1,150 GCC: 13 4,907 27 India: 3,757 India: 14 operating in Asia (GCC & India) PATIENT VISITS – FY21 CLINICS Present in 7 Countries GCC: ~13.9 mn (UAE, Saudi Arabia, Qatar, Oma
Slide 6: Aster DM Healthcare – Financial Overview
I I Aster DM Healthcare – Financial Overview Revenue - FY21 Revenue - FY21 India 19% Pharmacies 23% Hospitals 54% GCC Clinics 81% 23% EBITDA - FY21 IEIBITDA - FV21 Pharmacies 19% Note: 1. Revenue and EBITDA shown above excludes other income. 2. Above shown percentage of revenue and EBITDA by hospita
Slide 7: Geographical Footprint
I Geographical Footprint I Hospitals – 13 GCC Clinics – 106 Pharmacies – 223 Hospitals – 14 Clinics – 9 INDIA United Arab Emirates Kerala • Medcare Hospital, Dubai • Aster Medcity, Kochi • Medcare Orthopaedics and Spine Hospital • Aster MIMS, Calicut • Aster Hospital Mankhool • Aster MIMS, Kottakkal
Slide 8: Hospitals List
I I Hospitals List Hospita ls - GCC Loca tion Commencement/ Ca pa city Opera tiona l Ow ned Capacity Operational Acquisition Yea r Beds Beds / Lea sed Geography Medcare Hospital Dubai, UAE 2007 64 55 Leased Beds Beds Al Raffah Hospital Muscat, Oman 2009 86 72 Leased GCC 1,150 948 Al Raffah Hospital
Slide 9: Pipeline Projects
I I Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Aster Hospital Sharjah, UAE Greenfield 80 Q2 FY 2022 Construction Leased Aster Hospital Muscat, Oman Greenfield 145 Q4 FY 2022 Construction Leased Sanad Hospital Riyadh, Saudi
Slide 10: The Aster DM Healthcare Edge
I I The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder structure Differentiated Asset-light Business Model in
Slide 11: Aster DM Healthcare - Evolution
I I Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 2015: First clinic in Bahrain and in the Phi
Slide 12: Robust Growth Over Last 5 Years
I I ROBUST GROWTH OVER LAST 5 YEARS FY 21 numbers has an impact of COVID Inpatient Count (in '000) Aster DM - Revenue from Operations (INR Cr) f'f 1:\.) ,l e~e,\. \.91}0 AGR 13% exc\. FY 21) ,l ,t1, 'ft cfl.GV- 254 10% l 4 Yr C \.'2. 010 \ 220 5 Yr cAGR -> g 652 8,608 7.7 cfl.GV- _..,. 202 218 7,963
Slide 13: Aster – Overview
I I Aster – Overview ) Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 12
Slide 14: Aster - An Integrated Healthcare Provider
I I Aster - An Integrated Healthcare Provider FY21 Operational Information 2,200+ 2,20,000+ Cardiovascular IP Discharges Surgeries ~4.7 mn Clinic OPD Visits 16,100+ General - ~ ~ 1,300+ Bariatric Clinics $ 1 Surgeries ' j/ \ Surgeries ■ ₹ 6 0% 1,200+ / \ I ----- Joint 1,200+ ~ 7.5 mn Replacements •
Slide 15: Aster – A Healthcare Ecosystem
I I Aster – A Healthcare Ecosystem PATIENT LIFE CYCLE MANAGEMANT Aster, over 30 years, has created a healthcare eco-system across two geographical regions In GCC region, Aster’s primary care clinics i. act as the initial touch-points in the patient / ~ journey, while pharmacies and hospitals ,,•
Slide 16: GCC Healthcare – Unique Traits
I I GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat Population (mn) and working age population I Expat% -> 11 ~ss%1 I I ~ss%2 I Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) Due to lower % of o
Slide 17: Aster - Awards & Service Excellence
I I Aster - Awards & Service Excellence Padma Shri Award JCI Accreditation Dr. Azad Moopen, Chairman & Managing AHPI Awards Medcare Hospital Dubai, Medcare Director – Aster DM Healthcare received Medcity, CMI, MIMS Calicut, WIMS, Aadhar, Orthopedics and Spine Hospitals, Medcare “Padma Shri Award”, t
Slide 18: Key Highlights – FY21 Q4
I I Key Highlights – FY21 Q4 Clinical Highlights A 20-year-old male brought to ER at Ramesh Hospitals - Ongole with RTA and blunt injury to chest. ECHO showed cardiac tamponade. Patient developed asystole soon after arrival in ER. Within seconds, Chest wall opened in ER by Cardio Thoracic Surgeon,
Slide 19: Operational and Financial Overview
I I Aster – Overview ) Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 18
Slide 20: Revenue and Profitability Snapshot – FY21 Q4
I I Revenue and Profitability Snapshot – FY21 Q4 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) 1'2280 1' 2391 1' 336 1' 131 ~ 105 5% -l7% '<Oo 17.7% ~ 5.7% ~ FY20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20Q4 FY21 Q4 Constant currency growth of Revenue, EBITDA and PAT (Post NCI) is ~ 4%,
Slide 21: Revenue and Profitability Snapshot – FY21
I I Revenue and Profitability Snapshot – FY21 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ~ 8652 ~ 1258 ~ 1077 ~ 277 ~ 148 -1% -140 ---.:_..,.% 14.5% ----. 3.2% FY20 FY21 FY20 FY21 FY20 FY21 Constant currency growth of Revenue, EBITDA and PAT (Post NCI) is ~-4%, ~-18% and ~-
Slide 22: Geography-wise Financial – Snapshot Quarterly
Geography-wise Financial – Snapshot Quarterly I I GCC INDIA CONSOLIDATED FY20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 G Revenue (₹) 1,878 Cr 1,910 Cr 402 Cr 481 Cr 2,280 Cr 2,391 Cr G EBITDA (₹) 370 Cr 289 Cr 34 Cr 47 Cr 404 Cr 336 Cr G PAT (Post NCI) (₹) 135 Cr 132 Cr -4 Cr -27 Cr 131 Cr 105 Cr
Slide 23: Geography-wise Financial – Snapshot
Geography-wise Financial – Snapshot I I GCC INDIA CONSOLIDATED FY20 FY21 FY20 FY21 FY20 FY21 G Revenue (₹) 7,021 Cr 6,954 Cr 1,631 Cr 1,654 Cr 8,652 Cr 8,608 Cr G EBITDA (₹) 1,074 Cr 919 Cr 184 Cr 159 Cr 1,258 Cr 1,077 Cr G PAT (Post NCI) (₹) 293 Cr 239 Cr -16 Cr -91 Cr 277 Cr 148 Cr Notes: 1. Reven
Slide 24: Geography-wise Business – Snapshot Quarterly
I I Geography-wise Business – Snapshot Quarterly GCC INDIA CONSOLIDATED FY20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 Total Capacity Beds 1,111 1,150 3,693 3,757 4,804 4,907 Operational Beds 908 948 2,530 2,686 3,438 3,634 ALOS (Days) 2.0 2.2 3.5 3.8 2.9 3.2 Occupancy 58% 49% 56% 61% 57% 58% Outpa
Slide 25: Geography-wise Business – Snapshot
I I Geography-wise Business – Snapshot GCC INDIA CONSOLIDATED FY20 FY21 FY20 FY21 FY20 FY21 •e Total Capacity Beds Operational Beds 1,111 908 1,150 948 3,693 2,530 3,757 2,686 4,804 3,438 4,907 3,634 • ALOS (Days) 1.9 2.1 3.5 3.9 2.9 3.2 • Occupancy 56% 52% 61% 56% 60% 55% • Outpatient Visits In-pat
Slide 26: Segmental Performance FY21-Q4
I I Segmental Performance FY21-Q4 Growth % India - Unallocate India - Unallocate GCC GCC Hospitals, d& GCC GCC Hospitals, d& FY21 Q4 GCC Clinics Total GCC Clinics Total Hospitals Pharmacies Clinics and Elimination Hospitals Pharmacies Clinics and Elimination Labs s Labs s No. of Business Units (#) 1
Slide 27: Segmental Performance FY21
I I Segmental Performance FY21 India - India - Growth % Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY21 FY GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 106
Slide 28: Maturity Wise Hospital Performance – GCC FY21
I I Maturity Wise Hospital Performance – GCC FY21 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 11% 15% ₹66 3 57% 19.1% 0-3 Years ₹ 346 139 ₹ ~136,700 Over 3 85% 52% ₹463 Years 10 89% ₹ ~180,000 ₹ 2,823 809 16.4% 13
Slide 29: Maturity Wise Hospital Performance – India FY21
I I Maturity Wise Hospital Performance – India FY21 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 15% 15% ₹ 13 0-3 Years 3 ₹ ~28,600 63% 5.3% ₹ 240 404 Over 3 85% 55% ₹187 Years 10 85% ₹ ~30,400 13.5% ₹ 1,382 2,282
Slide 30: Financial Summary – Profitability Statement (1/2)
I I Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY21 Q3 FY20 Q4 FY21 Q4 Gw% Revenue from operations 2,228 2,280 2,391 5% Material consumption 651 676 665 Doctors cost 467 487 470 Employee cost (excl. doctors) 423 423 410 Laboratory outsourcing charges 72 8 140 Other expens
Slide 31: Financial Summary – Profitability Statement (2/2)
I I Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY20 FY21 Gw% Revenue from operations 8,652 8,608 -1% Material consumption 2,539 2,549 Doctors cost 1,926 1,779 Employee cost (excl. doctors) 1,666 1,620 Laboratory outsourcing charges 34 276 Other expenses 1,229 1,308 EBITDA
Slide 32: Financial Summary – Balance Sheet & Ratios
I I Financial Summary – Balance Sheet & Ratios As at Mar As at Mar Particulars (INR Cr) 31, 2020 31, 2021 LIABILITIES Shareholders Equity 3,272 3,372 Minority Interest 446 462 Gross Debt 2,972 2,309 Lease Liabilities - INDAS116 2,632 2,495 Other current and non-current liabilities 3,115 3,005 Total
Slide 33: Strategy and Leadership
I I (I Aster – Overview ) - ~ Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 32
Slide 34: ADMHL – Strategy & Outlook (1/2)
I I ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations
Slide 35: ADMHL – Strategy & Outlook (2/2)
I I ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant
Slide 36: India Strategy
India Strategy Aster DM Healthcare hopes to leverage its extensive experience In line with focus on derisking Focus on large format hospitals in Tier 1 of working in a 100% business – cities – Hospitals insurance market in target of 25% in Tier 1 cities the GCC to derive of overall estimated to bett
Slide 37: Aster Leadership Team
I I Aster Leadership Team Dr. Azad Moopen Veneeth Purushotaman Fara Siddiqi Chairman and Managing Director Group Chief Information Officer Group Chief Human Resource Officer Alisha Moopen Dr. Harish Pillai Brandon Rowberry Deputy Managing Director Chief Executive Officer –Aster India Chief Executive
Slide 38: Aster Board of Directors
I I Aster Board of Directors Daniel Robert Dr Layla Mohamed Dr. Azad Moopen Mintz Chairman and Managing Director Al-Marzooqi Non-Executive Director Independent Director Shamsudheen Bin t Alisha Moopen Deputy Managing Director Mohideen Mammu Haji Non-Executive Director C. John George Independent Dire
Slide 39: Thank You
JHANK YOU 38 www.asterdmhealthcare.com
Aster DM Healthcare — Q4 FY2021 Earnings Presentation on 6ix